Newsdesk, Author at Market Newsdesk

November 18, 2020 3:31 pm

Trulieve Launches TruSpectrum, Bringing the Future of Cannabis to Florida

PR Newswire

Oil-based vaporizer cartridges

made from whole-plant extract, TruSpectrum is a
new class of product

TALLAHASSEE, Fla., Nov. 18, 2020 /PRNewswire/ – Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) (“Trulieve”), a leading and top-performing cannabis company based in the United States, today announced the launch of a new product TruSpectrum. Trulieve’s TruSpectrum is a new class of product that provides whole-plant, full-spectrum relief made without additives or additional ingredients, in an oil-based, vaporizable format.

Trulieve TruSpectrum, a whole-plant extract product, contains cannabis-derived terpenes that are retained throughout the extraction process. The cannabinoids and terpenes come from a single strain of high-quality cannabis without any reintroductions resulting in a powerful, flavorful, and effective full-spectrum oil. TruSpectrum will be available in a portable, discrete vaporizer cartridge in Indica, Sativa, and Hybrid strains.

“Cannabis is unique because the plant offers so many medicinal benefits and that was the inspiration behind TruSpectrum. We wanted to create a product that offered patients the discretion of traditional vaporizers while still maintaining the integrity, the terpene profile, and the complex cannabinoid profile of the plant itself,” said Valda Coryat, Trulieve chief marketing officer. “TruSpectrum offers powerful relief while keeping what makes the plant unique and intact without the use of additives, alterations, or reintroductions.”

TruSpectrum launches in a half-gram TruPOD cartridge with plans to expand in the coming months. Patients will be able to purchase TruSpectrum at any of Trulieve’s 67 dispensaries across the state of Florida.

For more information, please visit www.Trulieve.com.

About Trulieve
Trulieve is a vertically integrated “seed-to-sale” company and is the first and largest fully licensed medical cannabis company in the State of Florida. Trulieve cultivates and produces all of its products in-house and distributes those products to Trulieve-branded stores (dispensaries) throughout the State of Florida, as well as directly to patients via home delivery. Trulieve also operates in California, Massachusetts, Connecticut, and Pennsylvania. Trulieve is listed on the Canadian Securities Exchange under the symbol TRUL and trades on the OTCQX market under the symbol TCNNF.

To learn more about Trulieve, visit www.Trulieve.com.

View original content:http://www.prnewswire.com/news-releases/trulieve-launches-truspectrum-bringing-the-future-of-cannabis-to-florida-301176410.html

SOURCE Trulieve Cannabis Corp.

November 18, 2020 3:23 pm

INVESTIGATION REMINDER: The Schall Law Firm Announces it is Investigating Claims Against Yalla Group Limited and Encourages Investors with Losses of $100,000 to Contact the Firm

INVESTIGATION REMINDER: The Schall Law Firm Announces it is Investigating Claims Against Yalla Group Limited and Encourages Investors with Losses of $100,000 to Contact the Firm

LOS ANGELES–(BUSINESS WIRE)–The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Yalla Group Limited (“Yalla” or “the Company”) (NYSE: YALA) for violations of the securities laws.

The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors. Yalla conducted its initial public offering (“IPO”) on or around September 30, 2020. The Company issued 18.6 million American depositary shares (“ADSs”) priced at $7.50 per ADS. The Company announced its unaudited third quarter 2020 financial results on November 9, 2020. The Company reported GAAP EPS of -$0.43 and costs of “$US64.7 million . . . compared with US$8.6 million in the same period last year.” The Company stated: “[t]he increase was primarily due to the recognition of share-based compensation of US$46.5 million upon our listing on the New York Stock Exchange on September 30, 2020. We granted a substantial amount of share options before the IPO but did not recognize any share-based compensation in prior periods because the exercisability of the options granted was conditional upon the completion of our IPO. Upon our listing on the NYSE, we immediately recognized a substantial amount of share-based compensation expenses associated with all outstanding options that were vested as of September 30, 2020.” Based on this announcement, the Company’s ADS price fell by more than 17% on November 10, 2020.

If you are a shareholder who suffered a loss, click here to participate.

We also encourage you to contact Brian Schall of the Schall Law Firm, 1880 Century Park East, Suite 404, Los Angeles, CA 90067, at 310-301-3335, to discuss your rights free of charge. You can also reach us through the firm’s website at www.schallfirm.com, or by email at [email protected].

The Schall Law Firm represents investors around the world and specializes in securities class action lawsuits and shareholder rights litigation.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.

View source version on businesswire.com: https://www.businesswire.com/news/home/20201118006035/en/

The Schall Law Firm

Brian Schall, Esq.

310-301-3335

[email protected]

www.schallfirm.com

KEYWORDS: California United States North America

INDUSTRY KEYWORDS: Legal Professional Services

MEDIA:

Logo

November 18, 2020 3:22 pm

ROSEN, A LEADING LAW FIRM, Reminds JPMorgan Chase & Co. Investors of Important December 23 Deadline in Securities Class Action First Filed by the Firm; Encourages Investors with Losses in Excess of $100K to Contact Firm – JPM

PR Newswire

NEW YORK, Nov. 18, 2020 /PRNewswire/ — Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of JPMorgan Chase & Co. (NYSE: JPM) between February 23, 2016 and September 23, 2020, inclusive (the “Class Period”), of the important December 23, 2020 lead plaintiff deadline in the securities class action. The lawsuit seeks to recover damages for JPMorgan investors under the federal securities laws.

To join the JPMorgan class action, go to http://www.rosenlegal.com/cases-register-1959.html or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] or [email protected] for information on the class action.

According to the lawsuit, defendants throughout the Class Period made false and/or misleading statements and/or failed to disclose that: (1) traders at JPMorgan, with the knowledge and consent of their superiors, manipulated the precious metals market by “spoofing,” or placing fake orders to generate the appearance of market demand; (2) JPMorgan had insufficient controls and compliance protocols to enable it to identify and stop the misconduct; (3) JPMorgan’s earnings in the physical commodity market were, at least in part, ill-gotten; (4) such conduct would result in enhanced regulatory scrutiny; (5) JPMorgan provided misleading information to CFTC investigators at early stages of the investigation into the misconduct; (6) resolution of the governmental investigation into JPMorgan would result in a record-breaking $920 million fine; and (7) as a result, defendants’ statements about JPMorgan’s business, operations, and prospects, were materially false and misleading and/or lacked a reasonable basis at all relevant times. When the true details entered the market, the lawsuit claims that investors suffered damages.

A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than December 23, 2020. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation. If you wish to join the litigation, go to http://www.rosenlegal.com/cases-register-1959.html or to discuss your rights or interests regarding this class action, please contact Phillip Kim, Esq. of Rosen Law Firm toll free at 866-767-3653 or via e-mail at [email protected] or [email protected].

NO CLASS HAS YET BEEN CERTIFIED IN THE ABOVE ACTION. UNTIL A CLASS IS CERTIFIED, YOU ARE NOT REPRESENTED BY COUNSEL UNLESS YOU RETAIN ONE. YOU MAY RETAIN COUNSEL OF YOUR CHOICE. YOU MAY ALSO REMAIN AN ABSENT CLASS MEMBER AND DO NOTHING AT THIS POINT. AN INVESTOR’S ABILITY TO SHARE IN ANY POTENTIAL FUTURE RECOVERY IS NOT DEPENDENT UPON SERVING AS LEAD PLAINTIFF.

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.

Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 3 each year since 2013. Rosen Law Firm has achieved the largest ever securities class action settlement against a Chinese Company. Rosen Law Firm’s attorneys are ranked and recognized by numerous independent and respected sources. Rosen Law Firm has secured hundreds of millions of dollars for investors. Attorney Advertising. Prior results do not guarantee a similar outcome.

Contact Information:

      Laurence Rosen, Esq.
      Phillip Kim, Esq.
      The Rosen Law Firm, P.A.
      275 Madison Avenue, 40th Floor
      New York, NY 10016
      Tel: (212) 686-1060
      Toll Free: (866) 767-3653
      Fax: (212) 202-3827
      [email protected]
      [email protected]
      [email protected]
      www.rosenlegal.com

View original content to download multimedia:http://www.prnewswire.com/news-releases/rosen-a-leading-law-firm-reminds-jpmorgan-chase–co-investors-of-important-december-23-deadline-in-securities-class-action-first-filed-by-the-firm-encourages-investors-with-losses-in-excess-of-100k-to-contact-firm–jpm-301176351.html

SOURCE Rosen Law Firm, P.A.

November 18, 2020 3:20 pm

RETA LOSS ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Reata Pharmaceuticals Inc.

PR Newswire

NEW YORK, Nov. 18, 2020 /PRNewswire/ — Bernstein Liebhard, a nationally acclaimed investor rights law firm, reminds investors of the lead plaintiff deadline in a securities class action that has been filed on behalf of investors that purchased or acquired the securities of Reata Pharmaceuticals Inc. (“Reata” or the “Company”) (NASDAQ: RETA) between October 15, 2019 and August 7, 2020 (the “Class Period”). The lawsuit filed in the United States District Court for the Eastern District of Texas alleges violations of the Securities Exchange Act of 1934.

If you purchased Reata securities, and/or would like to discuss your legal rights and options please visit Reata Shareholder Lawsuit or contact Matthew E. Guarnero toll free at (877) 779-1414 or [email protected].

The Complaint alleges that throughout the Class Period, Defendants made materially false and misleading statements regarding the Company’s business, operations and prospects. Specifically, Defendants made false and/or misleading statements and/or failed to disclose: (i) the MOXIe Part 2 study results were insufficient to support a single study marketing approval of omaveloxolone for the treatment of FA in the U.S. without additional evidence; (ii) as a result, it was foreseeable that the FDA would not accept marketing approval of omaveloxolone for the treatment of FA in the U.S. based on the MOXIe Part 2 study results; and (iii) as a result, the Company’s public statements were materially false and misleading at all relevant times.

On August 10, 2020, during pre-market hours, Reata issued a press release announcing its second quarter 2020 financial results, wherein it disclosed that the FDA is “not convinced that the MOXIe part 2 results” of the Company’s study assessing omaveleoxolone for the treatment of FA “will support a single study approval without additional evidence that lends persuasiveness to the results,” and that, “in preliminary comments for [a] meeting, the FDA stated that [Defendants] will need to conduct a second pivotal trial that confirms the mFARS results of the MOXIe part 2 study with a similar magnitude of effect.”

On this news, Reata’s stock price fell $51.79 per share, or 33.16% to close at $104.41 per share on August 10, 2020.

If you wish to serve as lead plaintiff, you must move the Court no later than December 14, 2020. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation. Your ability to share in any recovery doesn’t require that you serve as lead plaintiff. If you choose to take no action, you may remain an absent class member.

If you purchased Reata securities, and/or would like to discuss your legal rights and options please visit https://www.bernlieb.com/cases/reatapharmaceuticalsinc-reta-shareholder-class-action-lawsuit-stock-fraud-326/apply/ or contact Matthew E. Guarnero toll free at (877) 779-1414 or [email protected].

Since 1993, Bernstein Liebhard LLP has recovered over $3.5 billion for its clients. In addition to representing individual investors, the Firm has been retained by some of the largest public and private pension funds in the country to monitor their assets and pursue litigation on their behalf. As a result of its success litigating hundreds of lawsuits and class actions, the Firm has been named to The National Law Journal’s “Plaintiffs’ Hot List” thirteen times and listed in The Legal 500 for ten consecutive years.

ATTORNEY ADVERTISING. © 2020 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, (212) 779-1414. The lawyer responsible for this advertisement in the State of Connecticut is Michael S. Bigin. Prior results do not guarantee or predict a similar outcome with respect to any future matter.

Contact Information

Matthew E. Guarnero

Bernstein Liebhard LLP
https://www.bernlieb.com
(877) 779-1414
[email protected]

View original content to download multimedia:http://www.prnewswire.com/news-releases/reta-loss-alert-bernstein-liebhard-llp-reminds-investors-of-the-deadline-to-file-a-lead-plaintiff-motion-in-a-securities-class-action-lawsuit-against-reata-pharmaceuticals-inc-301170625.html

SOURCE Bernstein Liebhard LLP

November 18, 2020 3:20 pm

Draft of Accellera Portable Test and Stimulus Standard 2.0 Now Available for Public Review

ELK GROVE, Calif., Nov. 18, 2020 (GLOBE NEWSWIRE) —

What
:
Accellera Systems Initiative, the electronics industry organization focused on the creation and adoption of electronic design automation (EDA) and intellectual property (IP) standards, announced the availability of the Portable Test and Stimulus Draft Standard 2.0 (PSS) for public review. Downloa d the draft standard for review here.

The Portable Test and Stimulus Draft Standard 2.0 includes about 90% of the projected functionality that will be included in the official Portable Test and Stimulus Standard 2.0 release expected in March 2021. Accellera’s Portable Stimulus Working Group (PSWG) welcomes feedback from the community on the major additions included in the draft while the group finalizes the remaining functionality.

When:
Public review will open on November 18, 2020 and close on December 18, 2020.

About
:
New major features intend to improve the usability of the Portable Test and Stimulus Standard 2.0 and expand its portability and flexibility to a broader class of verification challenges.

Additions to the draft of the 2.0 standard include several new language features:

Core Library for standard portable functionality and utilities for common PSS applications, including register accesses and memory allocation and management
Collection types, including arrays, lists, maps, and sets
Parameterized types
Constraint enhancements, including default constraints and propagation
Enhanced activity-level generation and scheduling constructs
Improved portability of procedural constructs for test realization

How to participate and influence the standard:
The Portable Stimulus Working Group invites and encourages the community to participate in the review and provide feedback on the new additions to the standard.

Feedback can be provided through Accellera’s Portable Stimulus 2.0 Public Review Community Forum.

For more information on the working group and to view additional resources, visit the Portable Stimulus Working Group page.

About Accellera

Accellera Systems Initiative is an independent, not-for profit organization dedicated to create, support, promote and advance system-level design, modeling, and verification standards for use by the worldwide electronics industry. The organization accelerates standards development and, as part of its ongoing partnership with the IEEE, its standards are contributed to the IEEE Standards Association for formal standardization and ongoing change control. For more information, please visit www.accellera.org. Find out more about membership. Follow @accellera on Twitter or to comment, please use #accellera. Accellera Global Sponsors are: Cadence; Mentor, A Siemens Business; and Synopsys.

Accellera and
Accellera Systems Initiative
are trademarks of Accellera Systems Initiative Inc. All other trademarks and trade names are the property of their respective owners.

For more information, contact:

Barbara Benjamin
Public Relations for Accellera Systems Initiative
Phone: +1 503 209 2323
Email: [email protected]

November 18, 2020 3:17 pm

CI Financial Begins Trading on New York Stock Exchange, Completes Acquisition of Bowling Portfolio Management

CI Financial Begins Trading on New York Stock Exchange, Completes Acquisition of Bowling Portfolio Management

The dual-listed, Canadian-based asset and wealth management firm finalizes another U.S. RIA acquisition

TORONTO–(BUSINESS WIRE)–CI Financial Corp. (“CI”) (TSX: CIX) (NYSE: CIXX) announced today that it has completed the acquisition of Bowling Portfolio Management LLC (“Bowling”) of Cincinnati. CI also celebrated its cross-listing on the New York Stock Exchange (“NYSE”) yesterday, as U.S. shares commenced trading on the NYSE under the ticker symbol CIXX.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20201118006031/en/

Kurt MacAlpine, CEO of CI Financial celebrates listing the company’s common shares on the NYSE. (Photo: NYSE)

The U.S. listing and completed acquisition of Bowling highlight CI’s increasing focus on growth in the U.S. The acquisition of Bowling, which was previously announced on September 21, 2020, represents CI’s ninth finalized registered investment advisor (“RIA”) transaction this year.

“Completing the acquisition of Bowling and celebrating our cross-listing on the NYSE on the same day is a truly exciting moment for our firm and partners,” remarked Kurt MacAlpine, CEO of CI Financial. “As we expand our wealth management presence in North America by acquiring top-tier, well-run firms such as Bowling, we will now also be able to offer U.S. dollar-denominated stock in future acquisitions.”

As one of the fastest-growing RIA platforms in the U.S., CI has completed six direct acquisitions as well as three sub-acquisitions through CI affiliates since February. In addition to Bowling, CI now holds ownership interests in:

Balasa Dinverno Foltz LLC (Itasca, Illinois)
The Cabana Group, LLC (Fayetteville, Arkansas)
Congress Wealth Management, LLC (Boston)
One Capital Management, LLC (Westlake Village, California)
Surevest Private Wealth, LLC (Los Angeles/Phoenix)

CI has also recently announced an acquisition agreement for The Roosevelt Investment Group, Inc. of New York City, a full acquisition of Doyle Wealth Management, Inc. of Tampa, Florida; and a majority interest stake in Stavis & Cohen Financial, LLC of Houston. These transactions are expected to close prior to year-end, subject to customary closing conditions including regulatory approval.

The listing of CI Financial’s stock on the NYSE and the completed acquisition of Bowling support two of CI’s core mandates – globalizing the company and expanding its wealth management platform.

Following the close of all pending transactions, CI’s North American wealth management business will have approximately $83 billion (US$63 billion) in assets. CI’s total assets will reach a record $209 billion (US$157 billion). (Projections are based on asset levels as of October 31, 2020.)

About CI Financial

CI Financial Corp. is an independent company offering global asset management and wealth management advisory services. The company held total assets of C$202 billion as at October 31, 2020. CI’s primary asset management businesses are CI Global Asset Management and GSFM Pty Ltd., and it operates in wealth management through Assante Wealth Management (Canada) Ltd., CI Private Counsel LP, Aligned Capital Partners Inc., CI Direct Investing (WealthBar Financial Services Inc.), CI Investment Services Inc., Balasa Dinverno Foltz LLC, Bowling Portfolio Management LLC, The Cabana Group, LLC, Congress Wealth Management, One Capital Management, LLC, and Surevest LLC. CI trades on the Toronto Stock Exchange under the ticker symbol CIX and on the New York Stock Exchange under CIXX. Further information is available at www.cifinancial.com.

All financial amounts in Canadian dollars unless otherwise stated.

CI Global Asset Management is a registered business name of CI Investments Inc.

This press release contains forward-looking statements concerning anticipated future events, results, circumstances, performance or expectations with respect to CI Financial Corp. (“CI”) and its products and services, including its business operations, strategy and financial performance and condition. Forward-looking statements are typically identified by words such as “believe”, “expect”, “foresee”, “forecast”, “anticipate”, “intend”, “estimate”, “goal”, “plan” and “project” and similar references to future periods, or conditional verbs such as “will”, “may”, “should”, “could” or “would”. These statements are not historical facts but instead represent management beliefs regarding future events, many of which by their nature are inherently uncertain and beyond management’s control. Although management believes that the expectations reflected in such forward-looking statements are based on reasonable assumptions, such statements involve risks and uncertainties. The material factors and assumptions applied in reaching the conclusions contained in these forward-looking statements include that the investment fund industry will remain stable and that interest rates will remain relatively stable. Factors that could cause actual results to differ materially from expectations include, among other things, general economic and market conditions, including interest and foreign exchange rates, global financial markets, changes in government regulations or in tax laws, industry competition, technological developments and other factors described or discussed in CI’s disclosure materials filed with applicable securities regulatory authorities from time to time. The foregoing list is not exhaustive and the reader is cautioned to consider these and other factors carefully and not to place undue reliance on forward-looking statements. Other than as specifically required by applicable law, CI undertakes no obligation to update or alter any forward-looking statement after the date on which it is made, whether to reflect new information, future events or otherwise.

View source version on businesswire.com: https://www.businesswire.com/news/home/20201118006031/en/

Investor Relations

Jason Weyeneth, CFA

Vice-President, Investor Relations & Strategy

416-681-8779

[email protected]

Media Relations

United States

Trevor Davis

Gregory FCA for CI Financial

610-415-1145

[email protected]

Canada

Murray Oxby

Vice-President, Communications

416-681-3254

[email protected]

KEYWORDS: Ohio United States North America Canada

INDUSTRY KEYWORDS: Banking Professional Services Finance

MEDIA:

Logo

Photo

Kurt MacAlpine, CEO of CI Financial celebrates listing the company’s common shares on the NYSE. (Photo: NYSE)

November 18, 2020 3:14 pm

ROSEN, A TOP RANKED LAW FIRM, Reminds Bayerische Motoren Werke AG Investors of Important December 28 Deadline in Securities Class Action Commenced by the Firm – BMWYY, BAMXF

PR Newswire

NEW YORK, Nov. 18, 2020 /PRNewswire/ — Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Bayerische Motoren Werke AG (OTC: BMWYY, BAMXF) between November 3, 2015 and September 24, 2020, inclusive (the “Class Period”), of the important December 28, 2020 lead plaintiff deadline in the case first filed by the firm. The lawsuit seeks to recover damages for BMW investors under the federal securities laws.

To join the BMW class action, go to http://www.rosenlegal.com/cases-register-1749.html or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] or [email protected] for information on the class action.

According to the lawsuit, defendants throughout the Class Period made false and/or misleading statements and/or failed to disclose that: (1) BMW kept a “bank” of retail vehicle sales that it used to meet internal monthly sales targets regardless of when the sales actually occurred; (2) BMW artificially manipulated sales figures by having dealers register cars as sold when the cars were still in inventory; (3) as a result, BMW’s key operating metrics were inaccurate and misleading; and (4) as a result, defendants’ statements about BMW’s business, operations, and prospects were materially false and/or misleading and/or lacked a reasonable basis at all relevant times. When the true details entered the market, the lawsuit claims that investors suffered damages.

A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than December 28, 2020. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation. If you wish to join the litigation, go to http://www.rosenlegal.com/cases-register-1749.html or to discuss your rights or interests regarding this class action, please contact Phillip Kim, Esq. of Rosen Law Firm toll free at 866-767-3653 or via e-mail at [email protected] or [email protected].

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm or on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm.

Contact Information:

      Laurence Rosen, Esq.
      Phillip Kim, Esq.
      The Rosen Law Firm, P.A.
      275 Madison Avenue, 40^th Floor
      New York, NY 10016
      Tel: (212) 686-1060
      Toll Free: (866) 767-3653
      Fax: (212) 202-3827
      [email protected]
      [email protected]
      [email protected]
      www.rosenlegal.com

View original content to download multimedia:http://www.prnewswire.com/news-releases/rosen-a-top-ranked-law-firm-reminds-bayerische-motoren-werke-ag-investors-of-important-december-28-deadline-in-securities-class-action-commenced-by-the-firm–bmwyy-bamxf-301176352.html

SOURCE Rosen Law Firm, P.A.

November 18, 2020 3:11 pm

American Software’s Board Approves the Quarterly Cash Dividend

American Software’s Board Approves the Quarterly Cash Dividend

ATLANTA–(BUSINESS WIRE)–
American Software, Inc. (NASDAQ: AMSWA) today announced that its Board of Directors declared a quarterly dividend of $.11 per share. The dividend is payable to the Company’s Class A and Class B Shareholders of record at the close of business on February 5, 2021, to be paid on or about February 19, 2021.

About American Software, Inc.

Atlanta-based American Software, Inc. (NASDAQ: AMSWA), through its operating entities delivers an innovative technical platform with AI-powered capabilities for supply chain management and advanced retail planning that is accelerating digital supply chain optimization from product concept to customer availability. Logility, Inc., is helping large enterprise companies transform their supply chain operations to gain a competitive advantage. Recognized for its high-touch approach to customer service, rapid implementations and industry-leading return on investment (ROI), Logility customers include Big Lots, Husqvarna Group, Parker Hannifin, Sonoco Products and Red Wing Shoe Company. Demand Management, Inc. delivers affordable, easy-to-use supply chain planning solutions designed to increase forecast accuracy, improve customer service and reduce inventory to maximize profits and lower costs. Demand Management serves customers such as Siemens Healthcare, AutomationDirect.com and Newfoundland Labrador Liquor Corporation. New Generation Computing, Inc. powers the digital supply chain to enable apparel brand owners and retailers to maximize revenue and profit by accelerating lead times, streamlining product development, and optimizing sourcing and distribution. NGC customers include Brooks Brothers, Carter’s, Destination XL, Fanatics, Foot Locker, Jockey International, Lacoste and Spanx. The comprehensive American Software supply chain and retail planning portfolio delivered in the cloud includes advanced analytics, supply chain visibility, demand, inventory and replenishment planning, Sales and Operations Planning (S&OP), Integrated Business Planning (IBP), supply and inventory optimization, manufacturing planning and scheduling, retail merchandise and assortment planning and allocation, product lifecycle management (PLM), sourcing management, vendor quality and compliance, and product traceability. For more information about American Software, please visit www.amsoftware.com, call (404) 364-7615 or email [email protected].

Forward-Looking Statements

This press release contains forward-looking statements that are subject to substantial risks and uncertainties. There are a number of factors that could cause actual results to differ materially from those anticipated by statements made herein. These factors include, but are not limited to, changes in general economic conditions, technology and the market for the Company’s products and services, including economic conditions within the e-commerce markets; the timely availability and market acceptance of these products and services; the Company’s ability to satisfy in a timely manner all SEC required filings and the requirements of Section 404 of the Sarbanes-Oxley Act of 2002 and the rules and regulations adopted under that Section; the challenges and risks associated with integration of acquired product lines and companies; the effect of competitive products and pricing; the uncertainty of the viability and effectiveness of strategic alliances; and the irregular pattern of the Company’s revenues. For further information about risks the Company could experience as well as other information, please refer to the Company’s current Form 10-K and other reports and documents subsequently filed with the Securities and Exchange Commission. For more information, contact: Vincent C. Klinges, Chief Financial Officer, American Software, Inc., (404) 264-5477 or fax: (404) 264-5298.

American Software® is a registered trademark of American Software, Inc.. Other products mentioned in this document are registered marks, trademarks or service marks of their respective owners.

View source version on businesswire.com: https://www.businesswire.com/news/home/20201118006026/en/

Vincent C. Klinges

Chief Financial Officer

American Software, Inc.

(404) 264-5477

KEYWORDS: Georgia United States North America

INDUSTRY KEYWORDS: Supply Chain Management Retail Technology Logistics/Supply Chain Management Transport Other Technology Software

MEDIA:

November 18, 2020 3:08 pm

Surgery Partners, Inc. to Present at Upcoming Investor Conference

BRENTWOOD, Tenn., Nov. 18, 2020 (GLOBE NEWSWIRE) — Surgery Partners, Inc. (NASDAQ:SGRY) (“Surgery Partners” or the “Company”), a leading short-stay surgical facility owner and operator, today announced that Wayne S. DeVeydt, Executive Chairman of the Board, Eric Evans, Chief Executive Officer and Tom Cowhey, Chief Financial Officer will participate in the 2^nd Annual Wolfe Research Healthcare Conference on Thursday, November 19, 2020 at 9:00a.m. (Eastern Time).

Interested investors and other parties may listen to a simultaneous webcast of the event by logging onto the Investor Relations section of the company’s website at www.surgerypartners.com. The replay will also be available on this same website for a limited time following the call.

To learn more about Surgery Partners, please visit the Company’s website at www.surgerypartners.com. Surgery Partners uses its website as a channel of distribution for material Company information. Financial and other material information regarding Surgery Partners is routinely posted on the Company’s website and is readily accessible.

About Surgery Partners

Headquartered in Brentwood, Tennessee, Surgery Partners is a leading healthcare services company with a differentiated outpatient delivery model focused on providing high quality, cost effective solutions for surgical and related ancillary care in support of both patients and physicians. Founded in 2004, Surgery Partners is one of the largest and fastest growing surgical services businesses in the country, with more than 180 locations in 30 states, including ambulatory surgery centers, surgical hospitals, multi-specialty physician practices and urgent care facilities. For additional information, visit www.surgerypartners.com.

Contact:

Surgery Partners Investor Relations
(615) 234-8940
[email protected]

November 18, 2020 3:08 pm

Bad Bunny Hops To STXfilms’ “American Sole”

Film Stars Pete Davidson, O’Shea Jackson Jr., and Camila Mendes; Offset to Co-Star and Executive Produce the Film’s Soundtrack

PR Newswire

DOUGLAS, Isle of Man and BURBANK, Calif., Nov. 18, 2020 /PRNewswire/ — STXfilms, a division of Eros STX Global Corporation (NYSE:ESGC) (“ErosSTX”), has signed the internationally celebrated Latin Grammy Award-winning global superstar Bad Bunny to make his feature film debut in its upcoming film American Sole, opposite Pete Davidson, O‘Shea Jackson Jr., Camila Mendes, and Offset, who were previously announced in the cast. The announcement was made today by Adam Fogelson, chairman, STXfilms Motion Picture Group.

One of the most popular recording artists in the world and a phenomenon among Latin artists, Bad Bunny will have a supporting role currently being kept under wraps as it is crucial to the storyline.

American Sole follows two twenty-somethings (Davidson and Jackson) with mountains of college debt who use the fast cash of after-market sneaker reselling to achieve their American dream. But when their startup runs out of cash and a shady investor is their only way out, the dream quickly becomes a nightmare.

“We‘re tremendously excited by the way the cast is coming together and thrilled to have Bad Bunny joining this film,” said Fogelson. “As an actor, he‘ll provide not only incredible entertainment value but real authenticity to his role.”

American Sole is written and will be directed by Ian Edelman (HBO‘s “How to Make It in America,” Netflix‘s The After Party) and produced by Kevin Hart through his production company, HartBeat. Hart will be joined as producer by Jake Stein (Netflix‘s The After Party) through his Scondo Productions label, and NBA All-Star Chris Paul, who produces through his Ohh Dip!!! Productions banner. American Sole marks Paul‘s first feature film as producer. HartBeat‘s Bryan Smiley is executive producing along with Bad Bunny. Drew Simon and Patricia Braga will oversee the project for STXfilms. Liz Stephens negotiated the deals for the studio.

Bad Bunny is proclaimed as one of the most popular artists in the world. The multi-platinum artist, winner of the Latin GRAMMY and nominated for the GRAMMY, constantly manages to break language and stereotype barriers around the globe, becoming an international culture and entertainment icon. Following the huge impact he has had on mass audiences, Bad Bunny became the first Latin Reggaeton artist in history to appear on the cover of Rolling Stone magazine. He is also the second male personality to appear alone on the cover of Playboy magazine, after its founder, Hugh Hefner. His leadership within the Reggaeton and Trap genres has led him to dominate large stages during prominent music festivals and international concert tours.

His most recent album, “Las Que No Iban A Salir” debuted #1 on Billboard’s “Top Latin Albums,” dethroning himself over his previous albums, with “YHLQMDLG” at #2 and “X 100PRE” at #3. Bad Bunny is one of the Latin artists with the most entries to the global “Hot 100″ list, with a total of 24 hits. In addition, with his album “YHLQMDLG,” he became the first Latino artist in history to achieve the position #2 on the global list “Billboard 200.” Each of Bad Bunny’s releases has left their forceful mark on the history of Latin music. His artistic power and leadership in the entertainment world demonstrate his character as one of the most impactful artists of the moment and reaffirm his expansive position in the music industry.

Bad Bunny is represented by UTA and manager Noah Assad of Rimas Entertainment.

Eros STX Global Corporation:
Eros STX Global Corporation, (“ErosSTX” or “The Company”) (NYSE: ESGC) is a global entertainment company that acquires, co-produces and distributes films, digital content & music across multiple formats such as theatrical, television and OTT digital media streaming to consumers around the world. Eros International Plc changed its name to Eros STX Global Corporation pursuant to the July 2020 merger with STX Entertainment, merging two international media and entertainment groups. The combination of one of the largest Indian OTT players and premier studio with one of Hollywood‘s fastest-growing independent media companies has created an entertainment powerhouse with a presence in over 150 countries. ErosSTX delivers star-driven premium feature film and episodic content across a multitude of platforms at the intersection of the world‘s most dynamic and fastest-growing global markets, including US, India, Middle East, Asia and China. The Company also owns the rapidly growing OTT platform Eros Now which has rights to over 12,000 films across Hindi and regional languages and had 205.8 million registered users and 33.8 million paying subscribers as of June 30th, 2020. For further information, please visit ErosSTX.com.

STXfilms:
STXfilms, a division of Eros STX Global Corporation, is a next-generation film studio that produces, acquires, distributes, and markets motion pictures at scale. From blockbusters like Hustlers, Bad Moms, and The Upside to hits like The Gentlemen, Molly‘s Game, and The Gift, STXfilms produces star-driven films for a global audience. In just 5 short years, its slate of films has already grossed over $1.8b in global theatrical box office. With a wide range of partners including Universal Pictures Home Entertainment and Showtime (which handle the physical and premium television releases of STXfilms content, respectively), the studio is a fast-growing, industry powerhouse.

Contact:

Steve Elzer

[email protected]
213-607-3591

View original content to download multimedia:http://www.prnewswire.com/news-releases/bad-bunny-hops-to-stxfilms-american-sole-301176393.html

SOURCE STXfilms